Genotype-based changes in serum uric acid affect blood pressure

Kidney International

Volumn 81, Issue 5, 2012, Pages 502-507

  Parsa, Afshin ^a   Brown, Eric ^a   Weir, Matthew R ^a   Fink, Jeffrey C ^a   Shuldiner, Alan R ^a   Mitchell, Braxton D ^a   McArdle, Patrick F ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

blood pressure; hypertension; polymorphisms; proximal tubule

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; DIURETIC AGENT; GLUTAMATE TRANSPORTER; URIC ACID;

ADULT; AGED; ALLELE; AMBULATORY MONITORING; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GLUT9 GENE; HIGH SODIUM INTAKE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SLC2A9 GENE; SODIUM RESTRICTION; SYSTOLIC BLOOD PRESSURE; URIC ACID BLOOD LEVEL;

EID: 84857114575     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2011.414     Document Type: Article

References (42)

1. Cannon PJ, Stason WB, Demartini FE et al. Hyperuricemia in primary and renal hypertension. N Engl J Med 1966; 275: 457-464.
2. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA 2000; 283: 2404-2410. (Pubitemid 30257539)
3. Mellen PB, Bleyer AJ, Erlinger TP et al. Serum uric acid predicts incident hypertension in a biethnic cohort: the atherosclerosis risk in communities study. Hypertension 2006; 48: 1037-1042. (Pubitemid 44772705)
4. Perlstein TS, Gumieniak O, Williams GH et al. Uric acid and the development of hypertension: the normative aging study. Hypertension 2006; 48: 1031-1036. (Pubitemid 44772704)
5. Johnson RJ, Kivlighn SD, Kim YG et al. Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease. Am J Kidney Dis 1999; 33: 225-234. (Pubitemid 29072223)
6. Grayson PC, Kim SY, LaValley M et al. Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 2011; 63: 102-110.
7. Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med 2008; 359: 1811-1821.
8. Feig DI, Soletsky B, Johnson RJ. Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA 2008; 300: 924-932.
9. Goicoechea M, de Vinuesa SG, Verdalles U et al. Effect of allopurinol in chronic kidney disease progression and cardiovascular risk. Clin J Am Soc Nephrol 2010; 5: 1388-1393.
10. Kolz M, Johnson T, Sanna S et al. Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet 2009; 5: e1000504.
11. Li S, Sanna S, Maschio A et al. The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts. PLoS Genet 2007; 3: e194.
12. McArdle PF, Parsa A, Chang YP et al. Association of a common nonsynonymous variant in GLUT9 with serum uric acid levels in old order Amish. Arthritis Rheum 2008; 58: 2874-2881.
13. Vitart V, Rudan I, Hayward C et al. SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat Genet 2008; 40: 437-442. (Pubitemid 351450879)
14. Wallace C, Newhouse SJ, Braund P et al. Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia. Am J Hum Genet 2008; 82: 139-149. (Pubitemid 351735954)
15. Yang Q, Kottgen A, Dehghan A et al. Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors. Circ Cardiovasc Genet 2010; 3: 523-530.
16. Dehghan A, Kottgen A, Yang Q et al. Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet 2008; 372: 1953-1961.
17. Rule AD, de AM, Matsumoto M et al. Association between SLC2A9 transporter gene variants and uric acid phenotypes in African American and white families. Rheumatology (Oxford) 2010.
18. Tu HP, Chen CJ, Tovosia S et al. Associations of a non-synonymous variant in SLC2A9 with gouty arthritis and uric acid levels in Han Chinese subjects and Solomon Islanders. Ann Rheum Dis 2010; 69: 887-890.
19. Urano W, Taniguchi A, Anzai N et al. Association between GLUT9 and gout in Japanese men. Ann Rheum Dis 2010; 69: 932-933.
20. Caulfield MJ, Munroe PB, O'Neill D et al. SLC2A9 is a high-capacity urate transporter in humans. PLoS Med 2008; 5: e197.
21. Brandstatter A, Kiechl S, Kollerits B et al. Sex-specific association of the putative fructose transporter SLC2A9 variants with uric acid levels is modified by BMI. Diabetes Care 2008; 31: 1662-1667.
22. Doring A, Gieger C, Mehta D et al. SLC2A9 influences uric acid concentrations with pronounced sex-specific effects. Nat Genet 2008; 40: 430-436. (Pubitemid 351454014)
23. Augustin R, Carayannopoulos MO, Dowd LO et al. Identification and characterization of human glucose transporter-like protein-9 (GLUT9): alternative splicing alters trafficking. J Biol Chem 2004; 279: 16229-16236. (Pubitemid 38509316)
24. Anzai N, Ichida K, Jutabha P et al. Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans. J Biol Chem 2008; 283: 26834-26838.
25. Dinour D, Gray NK, Campbell S et al. Homozygous SLC2A9 mutations cause severe renal hypouricemia. J Am Soc Nephrol 2010; 21: 64-72.
26. Choi HK, Zhu Y, Mount DB. Genetics of gout. Curr Opin Rheumatol 2010; 22: 144-151.
27. Emmerson BT. Effect of oral fructose on urate production. Ann Rheum Dis 1974; 33: 276-280.
28. Gao X, Qi L, Qiao N et al. Intake of added sugar and sugar-sweetened drink and serum uric acid concentration in US men and women. Hypertension 2007; 50: 306-312. (Pubitemid 47205778)
29. Perheentupa J, Raivio K. Fructose-induced hyperuricaemia. Lancet 1967; 2: 528-531.
30. Doblado M, Moley KH. Facilitative glucose transporter 9, a unique hexose and urate transporter. Am J Physiol Endocrinol Metab 2009; 297: E831-E835.
31. Khosla UM, Zharikov S, Finch JL et al. Hyperuricemia induces endothelial dysfunction. Kidney Int 2005; 67: 1739-1742. (Pubitemid 40577708)
32. Mazzali M, Kanellis J, Han L et al. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol 2002; 282: F991-F997. (Pubitemid 34654464)
33. Kato M, Hisatome I, Tomikura Y et al. Status of endothelial dependent vasodilation in patients with hyperuricemia. Am J Cardiol 2005; 96: 1576-1578. (Pubitemid 41690182)
34. Khan F, George J, Wong K et al. The association between serum urate levels and arterial stiffness/endothelial function in stroke survivors. Atherosclerosis 2008; 200: 374-379.
35. Maxwell AJ, Bruinsma KA. Uric acid is closely linked to vascular nitric oxide activity. Evidence for mechanism of association with cardiovascular disease. J Am Coll Cardiol 2001; 38: 1850-1858. (Pubitemid 33116554)
36. Reynolds T. Serum uric acid, the endothelium and hypertension: an association revisited. J Hum Hypertens 2007; 21: 591-593. (Pubitemid 47162721)
37. Watanabe S, Kang DH, Feng L et al. Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity. Hypertension 2002; 40: 355-360. (Pubitemid 35006723)
38. Yu KH, Luo SF, Tsai WP et al. Intermittent elevation of serum urate and 24-h urinary uric acid excretion. Rheumatology (Oxford) 2004; 43: 1541-1545.
39. Feig DI, Johnson RJ. Hyperuricemia in childhood primary hypertension. Hypertension 2003; 42: 247-252. (Pubitemid 37093468)
40. Mitchell BD, McArdle PF, Shen H et al. The genetic response to short-term interventions affecting cardiovascular function: rationale and design of the Heredity and Phenotype Intervention (HAPI) Heart Study. Am Heart J 2008; 155: 823-828.
41. Lawlor DA, Harbord RM, Sterne JA et al. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med 2008; 27: 1133-1163. (Pubitemid 351395448)
42. Johnson RJ, Sanchez-Lozada LG, Nakagawa T. The effect of fructose on renal biology and disease. J Am Soc Nephrol 2010; 21: 2036-2039